<VariationArchive VariationID="654165" VariationName="NM_000533.5(PLP1):c.4+1del" VariationType="Deletion" Accession="VCV000654165" Version="7" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-29" DateCreated="2019-08-14" MostRecentSubmission="2024-07-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="653772" VariationID="654165">
      <GeneList>
        <Gene Symbol="PLP1" FullName="proteolipid protein 1" GeneID="5354" HGNC_ID="HGNC:9086" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>Xq22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="103776506" stop="103792619" display_start="103776506" display_stop="103792619" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="103031438" stop="103047547" display_start="103031438" display_stop="103047547" Strand="+" />
          </Location>
          <OMIM>300401</OMIM>
          <Haploinsufficiency last_evaluated="2021-04-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PLP1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-04-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PLP1">Sufficient evidence for dosage pathogenicity</Triplosensitivity>
        </Gene>
        <Gene Symbol="RAB9B" FullName="RAB9B, member RAS oncogene family" GeneID="51209" HGNC_ID="HGNC:14090" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>Xq22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="103776324" stop="103832257" display_start="103776324" display_stop="103832257" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="103077254" stop="103087211" display_start="103077254" display_stop="103087211" Strand="-" />
          </Location>
          <OMIM>300285</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000533.5(PLP1):c.4+1del</Name>
      <CanonicalSPDI>NC_000023.11:103776997:GGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq22.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="103776998" stop="103776998" display_start="103776998" display_stop="103776998" variantLength="1" positionVCF="103776997" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="103031926" stop="103031926" display_start="103031926" display_stop="103031926" variantLength="1" positionVCF="103031925" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000533.4" sequenceAccession="NM_000533" sequenceVersion="4" change="c.4+1delG">
            <Expression>NM_000533.4:c.4+1delG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.103031928del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.103031928del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.103777000del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.103777000del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008863.2" sequenceAccession="NG_008863" sequenceVersion="2" change="g.5490del">
            <Expression>NG_008863.2:g.5490del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016452.2" sequenceAccession="NG_016452" sequenceVersion="2" change="g.60285del">
            <Expression>NG_016452.2:g.60285del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001128834.3" sequenceAccession="NM_001128834" sequenceVersion="3" change="c.4+1del">
            <Expression>NM_001128834.3:c.4+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001582" Type="initiator_codon_variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000533.5" sequenceAccession="NM_000533" sequenceVersion="5" change="c.4+1del" MANESelect="true">
            <Expression>NM_000533.5:c.4+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001582" Type="initiator_codon_variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_199478.3" sequenceAccession="NM_199478" sequenceVersion="3" change="c.4+1del">
            <Expression>NM_199478.3:c.4+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001582" Type="initiator_codon_variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001305004.1" sequenceAccession="NM_001305004" sequenceVersion="1" change="c.4+1del">
            <Expression>NM_001305004.1:c.4+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001582" Type="initiator_codon_variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000533.5" sequenceAccession="NM_000533" sequenceVersion="5" change="c.4+1delG" MANESelect="true">
            <Expression>NM_000533.5:c.4+1delG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1602373055" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000533.5(PLP1):c.4+1del AND Hereditary spastic paraplegia 2" Accession="RCV000810065" Version="5">
        <ClassifiedConditionList TraitSetID="3068">
          <ClassifiedCondition DB="MedGen" ID="C1839264">Hereditary spastic paraplegia 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-08-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000533.5(PLP1):c.4+1del AND Pelizaeus-Merzbacher disease" Accession="RCV004595533" Version="1">
        <ClassifiedConditionList TraitSetID="3066">
          <ClassifiedCondition DB="MedGen" ID="C0205711">Pelizaeus-Merzbacher disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-11-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-11-22" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2019-08-14" MostRecentSubmission="2024-07-29">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16199547</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18470932</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9247276</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3066" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3286" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Pelizaeus Merzbacher brain sclerosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">LEUKODYSTROPHY, HYPOMYELINATING, 1</ElementValue>
                <XRef Type="MIM" ID="312080" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Pelizaeus-Merzbacher disease</ElementValue>
                <XRef ID="Pelizaeus-Merzbacher+disease/5643" DB="Genetic Alliance" />
                <XRef ID="64855000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sudanophilic leukodystrophy</ElementValue>
                <XRef ID="HP:0003269" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pelizeaus-Merzbacher spectrum disorder</ElementValue>
                <XRef ID="MONDO:0010714" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PMD</ElementValue>
                <XRef Type="MIM" ID="312080" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HLD1</ElementValue>
                <XRef Type="MIM" ID="312080" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">PLP1 disorders of central nervous system myelin formation include a range of phenotypes from Pelizaeus-Merzbacher disease (PMD) to spastic paraplegia 2 (SPG2). PMD typically manifests in infancy or early childhood with nystagmus, hypotonia, and cognitive impairment; the findings progress to severe spasticity and ataxia. Life span is shortened. SPG2 manifests as spastic paraparesis with or without CNS involvement and usually normal life span. Intrafamilial variation of phenotypes can be observed, but the signs are usually fairly consistent within families. Heterozygous females may manifest mild-to-moderate signs of the disease.</Attribute>
                <XRef ID="NBK1182" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">PLP1-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4265" />
                <XRef ID="4265" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301361</ID>
                <ID Source="BookShelf">NBK1182</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="AAP, 2021">
                <URL>https://publications.aap.org/pediatrics/article/148/3/e2021053126/181065/Leukodystrophies-in-Children-Diagnosis-Care-and</URL>
                <CitationText>Leukodystrophies in Children: Diagnosis, Care, and Treatment, Pediatrics (2021) 148 (3): e2021053126.</CitationText>
              </Citation>
              <XRef ID="702" DB="Orphanet" />
              <XRef ID="C0205711" DB="MedGen" />
              <XRef ID="MONDO:0010714" DB="MONDO" />
              <XRef Type="MIM" ID="312080" DB="OMIM" />
              <XRef Type="primary" ID="HP:0003269" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3068" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5933" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SPASTIC PARAPLEGIA 2, X-LINKED</ElementValue>
                <XRef Type="MIM" ID="312920" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia 2</ElementValue>
                <XRef ID="Spastic+paraplegia+2/6686" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary spastic paraplegia 2</ElementValue>
                <XRef ID="MONDO:0010733" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SPPX2</ElementValue>
                <XRef Type="MIM" ID="312920" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">SPG2</ElementValue>
                <XRef Type="MIM" ID="312920" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">PLP1-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4923" />
                <XRef ID="4923" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">PLP1 disorders of central nervous system myelin formation include a range of phenotypes from Pelizaeus-Merzbacher disease (PMD) to spastic paraplegia 2 (SPG2). PMD typically manifests in infancy or early childhood with nystagmus, hypotonia, and cognitive impairment; the findings progress to severe spasticity and ataxia. Life span is shortened. SPG2 manifests as spastic paraparesis with or without CNS involvement and usually normal life span. Intrafamilial variation of phenotypes can be observed, but the signs are usually fairly consistent within families. Heterozygous females may manifest mild-to-moderate signs of the disease.</Attribute>
                <XRef ID="NBK1182" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301361</ID>
                <ID Source="BookShelf">NBK1182</ID>
              </Citation>
              <XRef ID="99015" DB="Orphanet" />
              <XRef ID="C1839264" DB="MedGen" />
              <XRef ID="MONDO:0010733" DB="MONDO" />
              <XRef Type="MIM" ID="312920" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1844345" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="4976827|MedGen:C1839264" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000950252" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-08-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16199547</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18470932</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9247276</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9247276</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in PLP1 are known to be pathogenic (PMID: 18470932). Experimental evidence shows this variant results in a altered mRNA product that encodes a null allele (PMID: 9247276). This variant has been observed to segregate with¬†progressive, demyelinating peripheral neuropathy¬†in a family (PMID: 9247276). This variant is also known as G-4 deletion. This sequence change affects a donor splice site in intron 1 of the PLP1 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PLP1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.103031926del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1839264" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9877818" SubmissionDate="2024-07-12" DateLastUpdated="2024-07-29" DateCreated="2024-07-29">
        <ClinVarSubmissionID localKey="NM_000533.5:c.4+1delG" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005088451" DateUpdated="2024-07-29" DateCreated="2024-07-29" Type="SCV" Version="1" SubmitterName="Molecular Diagnostics Lab, Nemours Children's Health, Delaware" OrgID="28338" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9247276</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18470932</ID>
          </Citation>
          <Comment>This intronic variant (c.4+1delG) has not been observed in population databases (gnomAD). It has been described in the literature (PMID 9247276, PMID 18470932). The variant has been shown to segregate with disease in a large family, and studies indicate the deletion produces a null PLP1 allele with no protein expression.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Tissue>blood</Tissue>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <XRef DB="GTR" ID="GTR000028364.3" URL="http://www.ncbi.nlm.nih.gov/gtr/tests/28364/" />
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Hemizygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">6065</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PLP1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000533.5:intron 1</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="1602373055" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000533.5:c.4+1delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="312080" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14599858</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1844345" TraitType="Disease" MappingType="XRef" MappingValue="C1839264" MappingRef="MedGen">
        <MedGen CUI="C1839264" Name="Hereditary spastic paraplegia 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9877818" TraitType="Disease" MappingType="XRef" MappingValue="312080" MappingRef="OMIM">
        <MedGen CUI="C0205711" Name="Pelizaeus-Merzbacher disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

